[ad_1]
Australia's national science agency, CSIRO, is reviewing its links with a diet pill after it learned it was benefiting from the sale of a product that was not medical evidence.
Blackmores sells the Metabolic C12 supplement, under the umbrella of Impromy – a weight loss program developed by CSIRO.
CSIRO has contributed to the development of Impromy and the clinical validation of a related program called Flexi with Probiotec Limited.
Probiotec subsequently published the Metabolic C12 supplement, another Impromy brand product that has not been clinically validated by CSIRO.
Blackmores bought the Impromy brand from Probiotec last November.
CSIRO indicated that it was receiving 1% of all Impromy sales revenue, which includes Metabolic C12, and an additional 4% for future joint research.
CSIRO has not "clinically validated" Metabolic C12, a spokesman said.
"The way in which CSIRO's name is currently used in badociation with the Impromy program is outside the scope of what had been approved by CSIRO in the original agreement with Probiotec," the spokesman said. "Now that Blackmores has acquired Impromy, we are currently reviewing this legacy contract."
In addition to the use of the name CSIRO, he would also seek to align future royalties received on Impromy products that the agency has developed or clinically validated.
"All the revenue we receive from commercial partnerships is reinvested in science," the spokesman said.
Former marketing on Impromy's weight loss program Facebook page and current packaging tests at the University of Adelaide.
A screenshot of a message of Impromy weight loss program on Facebook Photo: Facebook / impromy weight loss program
A spokesman for a university said the product had not been developed nor tested by its researchers.
A spokesman said at the age that Metabolic C12 was nevertheless allowed to wear the name of the institution.
"University researchers (…) have conducted a series of studies all published in international scientific journals on the effects of lauric acid on hunger and energy intake, but not on the weight loss, "said a spokesman for the university.
"Our researchers say that at no time have they suggested that the results of this research indicate a benefit for weight loss. No studies have been conducted currently to study weight loss. "
Blackmores said the company adhered to some of the most stringent safety and quality standards in the world.
"Due to the reference to CSIRO on the packaging, we immediately took steps to remove the Metabolic C12 product from the sale," said a spokeswoman.
"Consumers can rest badured that there are no product safety issues."
Chemists sell 30 packages of Metabolic C12 at $ 19.99 and marketers say this product "helps boost metabolic function and can help weight loss by controlling hunger."
The Therapeutic Goods Administration has confirmed that it is investigating a formal complaint regarding Metabolic C12.
Source link
